The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005
Abstract
BACKGROUND: Studies have reported an increasing incidence of thyroid cancer since 1980. One possible explanation for this trend is increased detection through more widespread and aggressive use of ultrasound and image‐guided biopsy. Increases resulting from increased detection are most likely to involve small primary tumors rather than larger tumors, which often present as palpable thyroid masses. The objective of the current study was to investigate the trends in increasing incidence of differentiated (papillary and follicular) thyroid cancer by size, age, race, and sex. METHODS: Cases of differentiated thyroid cancer (1988‐2005) were analyzed using the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) dataset. Trends in incidence rates of papillary and follicular cancer, race, age, sex, primary tumor size (<1.0 cm, 1.0‐2.9 cm, 3.0‐3.9 cm, and >4 cm), and SEER stage (localized, regional, distant) were analyzed using joinpoint regression and reported as the annual percentage change (APC). RESULTS: Incidence rates increased for all sizes of tumors. Among men and women of all ages, the highest rate of increase was for primary tumors <1.0 cm among men (1997‐2005: APC, 9.9) and women (1988‐2005: APC, 8.6). Trends were similar between whites and blacks. Significant increases also were observed for tumors ≥4 cm among men (1988‐2005: APC, 3.7) and women (1988‐2005: APC, 5.70) and for distant SEER stage disease among men (APC, 3.7) and women (APC, 2.3). CONCLUSIONS: The incidence rates of differentiated thyroid cancers of all sizes increased between 1988 and 2005 in both men and women. The increased incidence across all tumor sizes suggested that increased diagnostic scrutiny is not the sole explanation. Other explanations, including environmental influences and molecular pathways, should be investigated. Cancer 2009. © 2009 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,369
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Larson, S. D., Jackson, L. N., Riall, T. S., Uchida, T., Thomas, R. P., Qiu, S., & Evers, M. B. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.12.037 · Cited by 216
Lifestyle and Other Risk Factors for Thyroid Cancer in Los Angeles County Females
Mack, W. J. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00281-2 · Cited by 124
The influence of dietary patterns on the development of thyroid cancer
Markaki, I., Linos, D. A., & Linos, A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00432-5 · Cited by 93
The Basis of Racial Differences in the Incidence of Thyroid Cancer
Morris, L. G. T., Sikora, A. G., Myssiorek, D. J., & DeLacure, M. D. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9812-6 · Cited by 65
Changing patterns of thyroid carcinoma
Dijkstra, B., Prichard, R. S., Lee, A., Kelly, L. M., Smyth, P. P. A., Crotty, T. B., McDermott, E. W. M., Hill, A. D. K., & O’Higgins, N. J. (2007) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-007-0041-y · Cited by 64
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Self-citationCancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Self-citationIntegrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., & Vigneri, R. (2013) · Journal of Cancer Epidemiology · doi:10.1155/2013/965212 · Cited by 1,288
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
Bongiovanni, M., Spitale, A., Faquin, W. C., Mazzucchelli, L., & Baloch, Z. W. (2012) · Acta Cytologica · doi:10.1159/000339959 · Cited by 1,032
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs491 · Cited by 993
Self-citationCancers with increasing incidence trends in the United States: 1999 through 2008
Simard, E. P., Ward, E. M., Siegel, R., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20141 · Cited by 724
Self-citationPizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., La Vecchia, C., & Vaccarella, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00035-3 · Cited by 658
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care
Morris, L. G. T., Sikora, A. G., Tosteson, T. D., & Davies, L. (2013) · Thyroid · doi:10.1089/thy.2013.0045 · Cited by 520
Thyroid Cancer Epidemiology and Prognostic Variables
Sipos, J. A., & Mazzaferri, E. L. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.05.004 · Cited by 514
Thyroid Cancer Gender Disparity
Rahbari, R., Zhang, L., & Kebebew, E. (2010) · Future Oncology · doi:10.2217/fon.10.127 · Cited by 511
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q.-Y., Ehya, H., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0040 · Cited by 510
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
Smallridge, R. C., & Copland, J. A. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.03.013 · Cited by 481
Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?
Pohl, H., Sirovich, B., & Welch, H. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0012 · Cited by 421
Bible, K. C., Suman, V. J., Molina, J. R., Smallridge, R. C., Maples, W. J., Menefee, M. E., Rubin, J., Sideras, K., Morris, J. C., McIver, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70203-5 · Cited by 421
Kim, T. H., Park, Y. J., Lim, J. A., Ahn, H. Y., Lee, E. K., Lee, Y. J., Kim, K. W., Hahn, S. K., Youn, Y. K., Kim, K. H., et al. (2012) · Cancer · doi:10.1002/cncr.26500 · Cited by 400
Vaccarella, S., Dal Maso, L., Laversanne, M., Bray, F., Plummer, M., & Franceschi, S. (2015) · Thyroid · doi:10.1089/thy.2015.0116 · Cited by 363
A Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and Histopathology
Wang, C.-C. C., Friedman, L., Kennedy, G. C., Wang, H., Kebebew, E., Steward, D. L., Zeiger, M. A., Westra, W. H., Wang, Y., Khanafshar, E., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0243 · Cited by 362
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pacini, F., Castagna, M. G., Brilli, L., & Pentheroudakis, G. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq190 · Cited by 350
Jung, C. K., Little, M. P., Lubin, J. H., Brenner, A. V., Wells, S. A., Sigurdson, A. J., & Nikiforov, Y. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2503 · Cited by 343
Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy
Nixon, I. J., Ganly, I., Patel, S. G., Palmer, F. L., Whitcher, M. M., Tuttle, R. M., Shaha, A., & Shah, J. P. (2012) · Surgery · doi:10.1016/j.surg.2011.08.016 · Cited by 333
Davies, L., Morris, L. G. T., Haymart, M., Chen, A. Y., Goldenberg, D., Morris, J., Ogilvie, J. B., Terris, D. J., Netterville, J., Wong, R. J., et al. (2015) · Endocrine Practice · doi:10.4158/ep14466.dscr · Cited by 327
Self-citationThyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pacini, F., Castagna, M. G., Brilli, L., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds230 · Cited by 290
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286
Zimmermann, M. B., & Galetti, V. (2015) · Thyroid Research · doi:10.1186/s13044-015-0020-8 · Cited by 279
Cramer, J. D., Fu, P., Harth, K. C., Margevicius, S., & Wilhelm, S. M. (2010) · Surgery · doi:10.1016/j.surg.2010.10.016 · Cited by 269
Li, N., Du, X. L., Reitzel, L. R., Xu, L., & Sturgis, E. M. (2013) · Thyroid · doi:10.1089/thy.2012.0392 · Cited by 262
Surgery for Papillary Thyroid Carcinoma: Is Lobectomy Enough?
Mendelsohn, A. H., Elashoff, D. A., Abemayor, E., & St John, M. A. (2010) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archoto.2010.181 · Cited by 261
Swierniak, M., Wojcicka, A., Czetwertynska, M., Stachlewska, E., Maciag, M., Wiechno, W., Gornicka, B., Bogdanska, M., Koperski, L., de la Chapelle, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1214 · Cited by 144
Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib
Capdevila, J., & Stjepanovic, N. (2014) · Biologics: Targets and Therapy · doi:10.2147/btt.s39381 · Cited by 85
Rubio, I. G. S., Galrão, A. L., Santo, M. A., Zanini, A. C., & Medeiros-Neto, G. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0452-8 · Cited by 58
Mischler, K., Kneifel, S., & Cathomas, R. (2016) · Oncology Research and Treatment · doi:10.1159/000448387 · Cited by 4
Metadata
- Authors
- Chen, A. Y., Jemal, A., & Ward, E. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-07-13
- Volume
- 115
- Issue
- 16
- Pages
- 3801-3807
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2040268038
- Cited by
- 988
- References
- 9
- FWCI
- 37.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.